3 months ago
LBPH
AnalystsPatrick TrucchioPatrick Trucchio's Stock Forecasts
AnalystsPatrick Trucchio
Analyst Ranking
Bottom 10%
#4138 out of 4554 analysts
Average Return
-1.75%
Win Rate
29%60 out of 204
Risk vs Reward
Poor
Good
Patrick Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +294.36% | $4.79 | $18.89 | 2023-03-14 - 2024-03-14 | Buy |
Silence Therapeutics PLCSLN | +265.17% | $6.03 | $22.02 | 2023-05-17 - 2024-04-18 | Buy |
Silence Therapeutics PLCSLN | +257.76% | $6.16 | $22.02 | 2023-05-10 - 2024-04-18 | Buy |
Silence Therapeutics PLCSLN | +223.35% | $6.81 | $22.02 | 2023-08-16 - 2024-04-18 | Buy |
Mind Medicine IncMNMD | +207.72% | $2.98 | $9.17 | 2023-03-15 - 2024-03-15 | Buy |
Patrick Trucchio Analyst Color
Get additional color on Patrick Trucchio's coverage of popular stocks
5 months ago
ALT
5 months ago
CYBN
2 years ago
VIR
Patrick Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Precision Biosciences IncDTIL | 8 | Buy | $60.00 | +459.70% | Reiterates | 2 days ago |
Longboard Pharmaceuticals IncLBPH | 8 | Buy | $60.00 | +233.15% | Reiterates | 4 days ago |
Atai Life Sciences NvATAI | 10 | Buy | $15.00 | +685.34% | Maintains | 17 days ago |
Altimmune IncALT | 9 | Buy | $12.00 | +74.17% | Maintains | 18 days ago |
Invivyd IncIVVD | 7 | Buy | $15.00 | +538.30% | Reiterates | a month ago |
Milestone Pharmaceuticals IncMIST | 9 | Buy | $25.00 | +1,433.74% | Reiterates | a month ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $30.00 | +297.35% | Initiates Coverage On | a month ago |
Sangamo Therapeutics IncSGMO | 10 | Buy | $5.00 | +930.93% | Reiterates | a month ago |
Silence Therapeutics PLCSLN | 11 | Buy | $75.00 | +240.60% | Reiterates | a month ago |
Vir Biotechnology IncVIR | 13 | Buy | $110.00 | +1,281.91% | Reiterates | a month ago |
Mind Medicine IncMNMD | 10 | Buy | $75.00 | +741.75% | Reiterates | a month ago |
Cybin IncCYBN | 10 | Buy | $5.00 | +1,251.35% | Maintains | a month ago |
Oncolytics Biotech IncONCY | 11 | Buy | $5.00 | +385.44% | Maintains | a month ago |
Gossamer Bio IncGOSS | 9 | Buy | $10.00 | +1,140.69% | Reiterates | a month ago |
Immunocore Holdings PLCIMCR | 9 | Buy | $90.00 | +64.41% | Reiterates | a month ago |
Alnylam Pharmaceuticals IncALNY | 15 | Buy | $395.00 | +172.11% | Reiterates | 2 months ago |
Gh Research PLCGHRS | 7 | Buy | $40.00 | +257.46% | Reiterates | 2 months ago |
Compass Pathways PLCCMPS | 7 | Buy | $120.00 | +1,325.18% | Reiterates | 2 months ago |
Uniqure NvQURE | 6 | Buy | $25.00 | +430.79% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 9 | Buy | $90.00 | +298.05% | Reiterates | 2 months ago |
Freeline Therapeutics Holdings PLCFRLN | 8 | Hold | $6.50 | +0.31% | Downgrades | 5 months ago |
Q32 Bio IncQTTB | 5 | Buy | $360.00 | +1,376.62% | Reiterates | a year ago |
Reunion Neuroscience IncREUN | 3 | Buy | $20.00 | N/A | Reiterates | a year ago |
Benitec Biopharma IncBNTC | 2 | Buy | $68.00 | N/A | Maintains | 2 years ago |
F Star Therapeutics IncFSTX | 4 | Hold | $7.00 | N/A | Downgrades | 2 years ago |
Arena Pharmaceuticals IncARNA | 2 | Hold | $100.00 | N/A | Downgrades | 2 years ago |
Allakos IncALLK | 2 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Flexion Therapeutics IncFLXN | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Mondaycom LtdMNDY | 1 | Buy | $340.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.